Literature DB >> 26858354

Identification of a novel stereotypic IGHV4-59/IGHJ5-encoded B-cell receptor subset expressed by various B-cell lymphomas with high affinity rheumatoid factor activity.

Richard J Bende1, Jerry Janssen2, Thera A M Wormhoudt2, Koen Wagner3, Jeroen E J Guikema2, Carel J M van Noesel2.   

Abstract

Entities:  

Keywords:  B-cell lymphoma; B-cell receptor; IGHJ5; IGHV4-59; rheumatoid factor

Mesh：

Substances：

Year:  2016        PMID： 26858354      PMCID： PMC5004362          DOI： 10.3324/haematol.2015.139626

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  20 in total

1.  Detection of minimal disease using rearranged immunoglobulin heavy chain genes from intermediate- and high-grade malignant B cell non-Hodgkins lymphoma.

Authors:  N van Belzen; P E Hupkes; D Doekharan; M Hoogeveen-Westerveld; L C Dorssers; M B van't Veer
Journal:  Leukemia       Date:  1997-10       Impact factor: 11.528

2.  Type II mixed cryoglobulinaemia as an oligo rather than a mono B-cell disorder: evidence from GeneScan and MALDI-TOF analyses.

Authors:  V De Re; S De Vita; D Sansonno; D Gasparotto; M P Simula; F A Tucci; A Marzotto; M Fabris; A Gloghini; A Carbone; F Dammacco; M Boiocchi
Journal:  Rheumatology (Oxford)       Date:  2006-01-06       Impact factor: 7.580

3.  Chronic lymphocytic leukemia cells recognize conserved epitopes associated with apoptosis and oxidation.

Authors:  Rosa Catera; Gregg J Silverman; Katerina Hatzi; Till Seiler; Sebastien Didier; Lu Zhang; Maxime Hervé; Eric Meffre; David G Oscier; Helen Vlassara; R Hal Scofield; Yifang Chen; Steven L Allen; Jonathan Kolitz; Kanti R Rai; Charles C Chu; Nicholas Chiorazzi
Journal:  Mol Med       Date:  2008-09-25       Impact factor: 6.354

4.  B-cell receptors expressed by lymphomas of hepatitis C virus (HCV)-infected patients rarely react with the viral proteins.

Authors:  Patrick P Ng; Chiung-Chi Kuo; Stanley Wang; Shirit Einav; Luca Arcaini; Marco Paulli; Carol S Portlock; Joseph Marcotrigiano; Alexander Tarr; Jonathan Ball; Ronald Levy; Shoshana Levy
Journal:  Blood       Date:  2014-01-21       Impact factor: 22.113

5.  Sequence analysis of the immunoglobulin antigen receptor of hepatitis C virus-associated non-Hodgkin lymphomas suggests that the malignant cells are derived from the rheumatoid factor-producing cells that occur mainly in type II cryoglobulinemia.

Authors:  V De Re; S De Vita; A Marzotto; M Rupolo; A Gloghini; B Pivetta; D Gasparotto; A Carbone; M Boiocchi
Journal:  Blood       Date:  2000-11-15       Impact factor: 22.113

6.  Hepatitis C virus drives the unconstrained monoclonal expansion of VH1-69-expressing memory B cells in type II cryoglobulinemia: a model of infection-driven lymphomagenesis.

Authors:  Maurizio Carbonari; Elisabetta Caprini; Tiziana Tedesco; Francesca Mazzetta; Valeria Tocco; Milvia Casato; Giandomenico Russo; Massimo Fiorilli
Journal:  J Immunol       Date:  2005-05-15       Impact factor: 5.422

7.  Control of autoantibody affinity by selection against amino acid replacements in the complementarity-determining regions.

Authors:  M Børretzen; I Randen; E Zdárský; O Førre; J B Natvig; K M Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

Review 8.  Chronic inflammatory disease, lymphoid tissue neogenesis and extranodal marginal zone B-cell lymphomas.

Authors:  Richard J Bende; Febe van Maldegem; Carel J M van Noesel
Journal:  Haematologica       Date:  2009-07-16       Impact factor: 9.941

9.  Somatic hypermutations confer rheumatoid factor activity in hepatitis C virus-associated mixed cryoglobulinemia.

Authors:  Edgar D Charles; Michael I M Orloff; Eiko Nishiuchi; Svetlana Marukian; Charles M Rice; Lynn B Dustin
Journal:  Arthritis Rheum       Date:  2013-09

10.  Among B cell non-Hodgkin's lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity.

Authors:  Richard J Bende; Wilhelmina M Aarts; Robert G Riedl; Daphne de Jong; Steven T Pals; Carel J M van Noesel
Journal:  J Exp Med       Date:  2005-04-18       Impact factor: 14.307
View more
  7 in total

Review 1.  Hepatitis C virus - associated B cell non-Hodgkin's lymphoma.

Authors:  Romeo-Gabriel Mihăilă
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

Review 2.  Structural Basis of a Conventional Recognition Mode of IGHV1-69 Rheumatoid Factors.

Authors:  Mitsunori Shiroishi
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

3.  Acquisition of N-Glycosylation Sites in Immunoglobulin Heavy Chain Genes During Local Expansion in Parotid Salivary Glands of Primary Sjögren Patients.

Authors:  Annie Visser; Marieke E Doorenspleet; Niek de Vries; Fred K L Spijkervet; Arjan Vissink; Richard J Bende; Hendrika Bootsma; Frans G M Kroese; Nicolaas A Bos
Journal:  Front Immunol       Date:  2018-03-12       Impact factor: 7.561

4.  Analysis of the B cell receptor repertoire in six immune-mediated diseases.

Authors:  R J M Bashford-Rogers; L Bergamaschi; E F McKinney; D C Pombal; F Mescia; J C Lee; D C Thomas; S M Flint; P Kellam; D R W Jayne; P A Lyons; K G C Smith
Journal:  Nature       Date:  2019-09-25       Impact factor: 49.962

5.  A Major Subset of Mutated CLL Expresses Affinity-selected and Functionally Proficient Rheumatoid Factors.

Authors:  Jerry Janssen; Naomi Donner; Zhen Li; Thera A M Wormhoudt; Koen Wagner; Jeroen E J Guikema; C Ellen van der Schoot; Arnon P Kater; Ten Feizi; Richard J Bende; Carel J M van Noesel
Journal:  Hemasphere       Date:  2021-03-23

6.  Repertoire Analysis of B-Cells Located in Striated Ducts of Salivary Glands of Patients With Sjögren's Syndrome.

Authors:  Annie Visser; Gwenny M Verstappen; Bert van der Vegt; Arjan Vissink; Richard J Bende; Hendrika Bootsma; Nicolaas A Bos; Frans G M Kroese
Journal:  Front Immunol       Date:  2020-07-14       Impact factor: 7.561

Review 7.  Base Excision Repair in the Immune System: Small DNA Lesions With Big Consequences.

Authors:  Maria Stratigopoulou; Tijmen P van Dam; Jeroen E J Guikema
Journal:  Front Immunol       Date:  2020-05-29       Impact factor: 7.561
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.